Analgesics - Indonesia | Statista Market Forecast

In Indonesia, the revenue generated in the Analgesics market in 2024 amounts to US$575.30m.
It is projected that the market will experience an annual growth rate of 9.05% from 2024 to 2029 (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in the Analgesics market, reaching US$7.24bn in 2024.
Considering the total population figures, per person revenues in Indonesia amount to US$2.06 in 2024.
Indonesia's analgesics market is experiencing a surge in demand as the population seeks relief from common ailments and chronic pain.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Indonesia is experiencing significant growth due to several factors. Customer preferences for pain relief products have shifted towards more convenient and accessible options, leading to an increase in demand for analgesics. Additionally, local special circumstances and underlying macroeconomic factors have also contributed to the development of the market.

Customer preferences: In Indonesia, customer preferences for pain relief products have evolved over time. Consumers are increasingly seeking convenience and accessibility in their healthcare products. This has led to a growing demand for analgesics, which offer quick and effective relief from pain. With busy lifestyles and limited time for traditional remedies, consumers are turning to analgesics as a convenient solution for managing pain.

Trends in the market: One of the key trends in the Analgesics market in Indonesia is the rising popularity of over-the-counter (OTC) analgesics. Consumers are increasingly self-medicating and are more willing to purchase OTC products for pain relief. This trend is driven by the convenience and accessibility of OTC analgesics, as they can be easily purchased without a prescription. The growing awareness and acceptance of self-medication practices have contributed to the increasing demand for OTC analgesics in the market.Another trend in the market is the introduction of innovative analgesic products. Manufacturers are constantly developing new formulations and delivery methods to cater to the evolving needs of consumers. This includes the development of topical analgesics, which provide targeted relief for specific areas of the body. These innovative products are gaining popularity among consumers who are looking for alternative pain relief options.

Local special circumstances: Indonesia has a large and growing population, which presents a significant market opportunity for analgesic manufacturers. The country's population is becoming more urbanized, leading to increased access to healthcare products. Additionally, the prevalence of chronic diseases and musculoskeletal disorders in Indonesia has also contributed to the demand for analgesics. With a growing aging population and changing lifestyles, the need for effective pain relief solutions is on the rise.

Underlying macroeconomic factors: The growing economy and increasing disposable income in Indonesia have also played a role in the development of the Analgesics market. As consumers have more purchasing power, they are able to afford healthcare products, including analgesics. The rising middle class in the country is driving demand for quality healthcare products, including pain relief options. Furthermore, the government's efforts to improve healthcare infrastructure and increase access to healthcare services have also contributed to the growth of the market.In conclusion, the Analgesics market in Indonesia is experiencing growth due to changing customer preferences, including a shift towards more convenient and accessible pain relief options. The market is also influenced by local special circumstances, such as the country's large and growing population and the prevalence of chronic diseases. Additionally, underlying macroeconomic factors, such as the growing economy and increasing disposable income, have contributed to the development of the market. As the market continues to evolve, manufacturers are likely to focus on introducing innovative products that cater to the specific needs of Indonesian consumers.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.